
Article Fingerprint
ReserarchID
MRB96Y6
Choose where you want to hide AI Takeaway. Your site-wide choice will be remembered in this browser.
Cetuximab, an anti-epidermal growth factor receptor (EGFR) antibody, has been widely used for therapy of several kinds of malignant diseases. However, the anticancer effect is incomplete. The purpose of this study was to examine the synergism between the herbal drug, Polysaccharide K, and Cetuximab against gastrointestinal cancer cell lines in vitro and in vivo. Two gastrointestinal cancer cell lines positive for EGFR expression were used for this study. In the in vivo study, mice were xenografted with cancer cell lines subcutaneously. Neither PSK nor Cetuximab suppressed cell proliferation. However, when both drugs were administered, cancer growth was suppressed significantly compared with treatment with Cetuximab alone. This study demonstrated that PSK has the potential to enhance Cetuximab’s effect on gastrointestinal cancer.
hara masa, mshara, [email protected]. 2013. "The Herbal Drug, Polysaccharide K, has an Immunological and Synergistic Anticancer Effect with Cetuximab for Gastrointestinal Cancer in Vivo". Global Journal of Medical Research - I: Surgeries & Cardiovascular System GJMR-I Volume 13 (GJMR Volume 13 Issue I3).
Crossref Journal DOI 10.17406/gjmr
Print ISSN 0975-5888
e-ISSN 2249-4618
v1.2
Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.
Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.
Total Score: 188
Country: Japan
Subject: Global Journal of Medical Research
Authors: Masayasu Hara, Takaya Nagasaki, Hiromitsu Takeyama (PhD/Dr. count: 0)
View Count (all-time): 261
Total Views (Real + Logic): 1872
Total Downloads (simulated): 130
Publish Date: 2013 05, Wed
Monthly Totals (Real + Logic):
We use cookies and similar technologies to improve site performance, understand traffic, and enhance your publishing experience. Cookie Policy
Choose which optional cookies Global Journals can use. Your preference applies across this platform and can be updated any time.
These cookies are required for core website functionality and security.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.